A new tumour associated antigen of non-small cell lung cancer: Tumour liberated proteins (TLP) - A possible new tumor marker

Anticancer Research

Volumn 16, Issue 4 B, 1996, Pages 2253-2255

  Garaci, E ^a   Sinibaldi, P ^a   Rasi, G ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CNR   (Italy)

Author keywords

Lung cancer; TAA; TLP; Tumor marker

Indexed keywords

ANTIBODY; SYNTHETIC PEPTIDE; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ANTIBODY PRODUCTION; ARTICLE; BLOOD DONOR; CANCER STAGING; CHRONIC LUNG DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RABBIT; RISK;

ANIMALS; ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUNG NEOPLASMS; RABBITS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0029837226     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Minna JD, Pass H, Glatstein E et al: Cancer of the lung, in De Vita LT, Hellmann S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology. Philadelphia, PA, Lippincott, pp591-705, 1989.
2. Mountain CF: Prognostic implications of the international staging system for lung cancer. Semin Oncol 15: 236-245, 1988.
3. Boring CC, Squires TS, Tong T: Cancer statistics, CA 1992; 42: 19-38, 1992.
4. Gadzar AF, Carney DN, Becker KL et al: Expression of peptide and other markers in lung cancer cell lines. Cancer Res 99: 177-180, 1985.
5. Van der Gaast A, Schoenmakers CHH et al: Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1. Br J Cancer 69: 525-528, 1994.
6. Tarro G, Pederzini A et al: Human tumor antigens inducing in vivo delayed hypersensitivity and in vitro mitogenic activity. Oncology 40: 248-254, 1983.
7. Tarro G, Marshak DR, Perna A, Esposito C: Antigenic regions of tumor liberated protein complexes and antiboties against the same. Biomed and Pharmacother 47: 237-240, 1993.
8. American Joint Commitee on Cancer, Task Force on Lung: Slanging of Lung Cancer 1979. Chicago, American Joint Commitee on Cancer 1974.
9. Batess SE: Clinical applications of serum tumour markers. Ann Intern Med 115: 623-638, 1991.
10. Margolis ML, Hyzy JB et al: Serum Tumor Markers in Non-Small cell lung cancer. Cancer 73: 605-609, 1994.
11. Buccheri G, Violante B, Sartoris AM et al. Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma.